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The human breast parenchyma consists of collecting ducts and
terminal duct lobular units (TDLUs). The TDLU is the site of origin
of most breast cancers. The reason for such focal susceptibility to
cancer remains poorly understood. Here, we take advantage of a
region-specific heterogeneity in luminal progenitors to interro-
gate the differentiation repertoire of candidate stem cells in
TDLUs. We show that stem-like activity in serial passage culture
and in vivo breast morphogenesis relies on the preservation of a
myoepithelial phenotype. By enrichment for region-specific
progenitors, we identify bipotent and multipotent progenitors
in ducts and TDLUs, respectively. We propose that focal breast
cancer susceptibility, at least in part, originates from region-
specific myoepithelial progenitors.
breast | myoepithelial cell | stem cell | progenitors
It is increasingly appreciated that the site of origin of cancer atthe histological level impacts severely on the tumor phenotype
and the course of disease (1). The human breast consists of ducts
which end in facultative secretory units referred to as terminal
duct lobular units (TDLUs). The permanent presence of rela-
tively well-developed, albeit resting, TDLUs under nonlactating
conditions is a hallmark of the human breast (2, 3). This seems to
be highly relevant from a cancer perspective because, presumably,
around three-fourths of all human breast cancers arise specifically
in TDLUs (1). Indeed, both the mammographic and histological
presentations and clinical outcomes are entirely different between
TDLU- and duct-derived breast cancers (1). Hence, given the
rising appreciation of predecessor cells as impacting on tumor
phenotypes, it is tempting to speculate that TDLUs and ducts rely
on different cells for maintenance of tissue homeostasis and, in
turn, tumor initiation. Indeed, our previous studies suggest that
the anatomical location of a stem cell zone may be of relevance for
the characteristics of the generated progenitors of luminal cells
(4). Here, we decided to take advantage of early observations that
TDLUs and ducts differ by cytokeratin 19 (K19) expression (5).
The TDLUs are often heterogeneous, while the ducts consistently
are homogeneously K19+. Moreover, the likely TDLU-derived
benign breast lesions are also heterogeneous, while the duct-
derived papillomas are homogeneously K19+ (5). These differ-
ences were all found within the luminal epithelial lineage. More
recently, it has been overwhelmingly demonstrated that the lu-
minal epithelial lineage originates from stem cells residing within
the myoepithelial lineage (6–8). Moreover, alteration of the PI3K
signaling pathway in mice leads to destabilization of the myoepi-
thelial lineage and generation of luminal tumors (9). Therefore, to
examine the cellular source of heterogeneity within the luminal
lineage, measures to address progenitor cells within the myoepi-
thelial lineage are highly warranted.
All attempts so far to measure human breast progenitor cell
activity have suffered from lack of control of lineage, as well as
contamination by primary luminal cells (4, 6). Thus, in short-
term culture deprived of the in vivo niche, myoepithelial cells
(MEPs) have a tendency to undergo squamous metaplasia (10).
Furthermore, in long-term culture, MEPs lose myodifferentiation
permanently and fail to generate fully differentiated luminal cells
(10–12). We here hypothesized that maintenance of the myoepi-
thelial phenotype is critical for sustained progenitor cell activity,
and that this requires continuous input from stroma. We describe
a protocol that includes stromal feeders for serial subculture of
MEPs with preserved phenotypic traits, progenitor cell activity,
and no luminal contamination. Progenitor cell activity is revealed
by clonal conversion into a luminal lineage upon feeder depri-
vation and correlates with in vivo breast morphogenesis upon
transplantation to mice.
We show that the human breast contains two different pro-
genitors: one residing within TDLUs, which is responsible for the
typical luminal heterogeneity therein, and another in ducts,
which has the potential to generate a homogeneous luminal
lineage. We propose that this anatomy is the underlying cause of
site-specific cancer susceptibility in the human breast.
Results
Luminal Heterogeneity in the Human Breast Is Region-Specific and
Acquired. Simple keratins, such as K18 and K19, have been
used successfully as readouts for stem cell activity in cultures of
the human breast (4, 13–15). Among these, in particular, a
heterogeneous staining for K19 in TDLUs and a homogeneous
staining in interlobular ducts have been interpreted in favor of
the existence of a breast stem cell hierarchy which is disrupted in
breast cancer (5). Here, we tested this staining pattern with one
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of the originally applied antibodies (BA16) on a sample of
38 normal biopsies. In all cases, interlobular ducts were homo-
geneously K19+ (Fig. 1). Heterogeneity within TDLUs, here
operationally defined as the presence of heterogeneous staining
with K19 in more than one-third of the TDLUs in a given biopsy,
increased with age (Fig. 1 and SI Appendix, Fig. S1). That the
K19+ cells indeed qualified as luminal cells was further sup-
ported by coexpression of K19 and the key luminal marker
MUC1 (16, 17) (SI Appendix, Fig. S2), amounting to an average
of 63 ± 13% of K19+ cells with MUC1 expression in smears from
three biopsies. A linear correlation between heterogeneity and
age could, however, not be established (Spearman’s rank corre-
lation, P = 0.07), indicating that factors other than age per se
may influence the pattern of K19 expression. One such factor is
parity. In the present biopsy material, information about parity
was not available, but among Danish women, less than 2% give
birth before the age of 21 y (Statistics Denmark; www.Statbank.
dk/FODP). Thus, we divided the material into two groups based
on age below and above the age of 21 y. Heterogeneity was
observed in one of 12 (8%) of the biopsies from women younger
than 21 y of age and in 11 of 26 (42%) biopsies among women
aged 21 to 59 y (Table 1). Aside from the one very heteroge-
neous biopsy among those from younger women, defined as an
outlier based on the interquartile range method, the rest are
significantly different from the group of older women (Mann–
Whitney U test, P < 0.05). These data suggest that luminal
heterogeneity is acquired specifically within the TDLUs. In light
of our current understanding of luminal progenitors as being
located downstream of myoepithelial stem cells, this raised the
fundamental question of whether more than one myoepithelial
progenitor cell compartment is responsible for sculpting the lu-
minal lineage in the human breast, that is, whether ducts and
lobules harbor different myoepithelial progenitor cells.
Control of Luminal Progenitor Formation from 2D Ultrapure MEPs. In
previous work, we and others demonstrated that human MEPs
under standard culture conditions rapidly lose the ability to dif-
ferentiate into luminal epithelial cells (11, 12, 18). In the present
work, to gauge for progenitor cell activity in TDLU- and duct-
derived cells, respectively, we first developed a scalable, cell-
based, serial passage subculture assay. Accordingly, we tested if a
recently established 2D culture system for a highly uniform clo-
nogenic ground state of intestinal stem cells (19, 20) could be
modified to facilitate “ground state” human breast MEPs. Since
freshly isolated human breast cells have been reported to contain
about 8% multilineage progenitors (21) and some fluorescence-
activated cell sorting (FACS) protocols for myoepithelial purifica-
tion operate with contamination with primary luminal cells on the
same order of magnitude (7), we first compared three established
protocols (6, 22, 23) for their efficiency in recovering a pure
myoepithelial population. As seen in Fig. 2A, irrespective of the
Fig. 1. Luminal heterogeneity is region-specific and acquired. Representa-
tive cryostat sections from a sample of reduction mammoplasties with
prominent TDLUs, including 12 biopsies from women below the age of 21 y
and 26 biopsies from women above the age of 21 y. All sections were stained
for K19 by immunoperoxidase, and nuclei were counterstained with he-
matoxylin. Among younger women, almost all biopsies contained homo-
geneously K19+ TDLUs (A); however, heterogeneity among TDLUs, defined
as the presence of both prominent homogeneously K19+ TDLUs and K19+/−
TDLUs in the same section, was recorded primarily among women older than
21 y (C). (B and D) In both categories, ducts were homogeneously K19+.
(Scale bar: 50 μm.)
Table 1. List of biopsies used for heterogeneity scoring
Biopsy Age, y Heterogeneity score* Frequency, %
P957 19 1/12 8
P985 19 2/15 13
P722/1 20 2/15 13
P648 13 0/14 0
W428/1 17 0/33 0
W432/1 18 4/31 13
W445/1 20 0/13 0
W466/3 18 3/11 27
F526 19 0/5 0
P944/2 18 0/6 0
P816 20 0/45 0
W430/1a 17 4/6 67
P967 34 4/8 50
P959/1 45 5/14 36
P954/1 39 2/11 18
P940/1 59 5/12 42
P931 44 4/8 50
P800 45 2/42 5
P737 44 0/20 0
P727/1 44 4/12 33
P832/1 32 3/26 12
P672/1 30 0/16 0
P837 23 7/14 50
P647/1 56 0/8 0
P670/3 42 7/18 39
P765 34 13/34 38
P819 45 0/14 0
P820 29 9/25 36
F498 46 11/47 23
P966 41 0/12 0
W430/2 59 7/35 20
W901 43 7/19 37
W1908/1 23 1/14 7
P653/1 40 2/18 11
P683/1 33 1/22 5
P941 27 13/24 54
F518s 24 0/26 0
W438 46 12/49 24
*Heterogeneity is scored as the number of K19 heterogeneous TDLUs/total
number of TDLUs. Only biopsies with a frequency of 33% or higher were
scored as positive.














FACS protocol applied, luminal contamination varied from
3 to 15%, which was considered too close to the hypothetical
number of stem cells in the breast to represent a safe starting
point. In an attempt to completely free the sorted population
from luminal cells, we therefore tested the condition supportive
of the intestinal ground state [i.e., a feeder of irradiated NIH
3T3 fibroblasts (19)] for its ability to select for myoepithelial
plating and propagation when grown in a culture medium de-
vised specifically for preservation of epithelial traits in culture
[modified breastoid base medium with Y-27632, adenine, and
serum replacement B27 (BBMYAB)] (22, 24), here termed
Myo medium. While contaminating luminal cells plated and grew
when seeded on plastic, this was not the case upon seeding on
fibroblast feeders (Fig. 2B). By this protocol, ultrapure primary
cultures of MEPs could be reproducibly generated from the
CD326low/CD271high gate of FACSs from a sample of 25 randomly
selected biopsies.
Once purified, it was essential to further expand MEPs expo-
nentially in a scalable manner without spontaneous differentiation
into luminal progenitors. We noted that the culture-induced ir-
reversible loss of myoepithelial differentiation reported by us and
others implicates the use of epidermal growth factor in the
culture medium (10, 25, 26). Since MEPs in culture are either
epithelium-like with little or no myodifferentiation or more
mesenchymal-like cells with a full complement of myodiffer-
entiation, we sought to examine both of these states of differ-
entiation for their ability to serve in an assay for proper breast
progenitor cell activity. For this purpose, we slightly modified a
culture medium originally devised for long-term culture of
human epithelial cells (FAD2) (27), here termed Epi medium,
for comparison with the Myo medium. As seen in Fig. 2C, both
media supported longevity, as revealed by growth for more than
25 population doublings. In the lower passages, the cultures could
be split up to 1:40 and cultures could reach up to 10 passages,
corresponding to approximately 2 mo in culture, before the cells
senesced. Cultured normal human breast epithelial cells are
known to encounter senescence barriers of which the first, stasis, is
characterized by elevated levels of CDKN2A/p16INK4A (p16) (28).
Here, up-regulation of p16 protein expression in passage 5 sug-
gests that stasis is reached after 15–20 population doublings (SI
Appendix, Fig. S3).
Using these conditions, we found that myoepithelial-derived
cells in the presence of fibroblast feeders and irrespective of the
applied culture medium completely refrained from luminal dif-
ferentiation at any given time point during serial-passage sub-
culture (Fig. 3 and SI Appendix, Fig. S4). The two media did,
however, impact significantly on the differentiation repertoire.
Both conditions supported expression of myoepithelial K14 and
K5, as well as p63. However, whereas in Epi medium, the cells
were nonmyodifferentiated myoepithelial cells (NMMEPs)
exhibiting a relatively low expression of CD271, in Myo medium,
the cells maintained critical differentiated traits of MEPs, in-
cluding α-smooth muscle actin, vimentin, CD90, and CD271
(Fig. 3 and SI Appendix, Figs. S5 and S6). This was further
confirmed by whole-transcript expression analysis and profiling
(Fig. 4A). While NMMEPs exhibited high expression of tran-
scripts related to keratinocyte and skin differentiation, MEPs
highly expressed transcripts related to myodifferentiation (Fig.
4A). Switching the two culture media revealed that differentiation
was unidirectional and that loss of myoepithelial differentiation
was irreversible since MEPs became nonmyodifferentiated upon
exposure to Epi medium, and upon switching to Myo medium,
they remained epithelial, and myoepithelial characteristics were
not gained.
Once verified as pure NMMEPs and MEPs, respectively, the
cells’ differentiation repertoire was further confirmed by in
vivo orthotopic transplantation to NOG mice. MEPs developed
into typical double-layered structures, including an outer layer of
α-smooth muscle actin–positive MEPs, while the NMMEPs
formed a lineage-restricted stratified epithelium without MEPs
but with squamous characteristics, including K10 expression
(Fig. 4B). Importantly, concomitant with their α-smooth muscle
actin expression, MEPs performed in mice up to culture pas-
sage 4 without significant loss of morphogenic ability. This led
us to conclude that we now are in possession of an ultrapure
MEP serial-passage subculture protocol with preserved tissue-
specific progenitor cell activity and, most importantly, that
relevant breast progenitor cell activity relies on preserved
myoepithelial differentiation.
Fig. 2. Establishment of ultrapure 2D myoepithelial cultures as a source of
luminal progenitors. (A, Top) FACS diagrams of MEPs from three independent
reduction mammoplasties (P936, P954, and P964) sorted by three different
protocols based on the application of a common antibody against luminal
epithelial cells, CD326, in combination with one of the three myoepithelial
markers: CD271 (Left), CD29 (Middle), and CD49f (Right). The circles indicate
the approximate gates selected for sorting. (A, Bottom) Histograms based on
quantification of luminal contamination as revealed by staining of K19 in
smeared uncultured cells directly from FACS show contaminating luminal cells
under all conditions, albeit at the lowest frequency with the CD271 protocol
(error bars indicate SD). (B) MEPs from another biopsy (P963) sorted by the
CD326/CD271 protocol (Left) and plated on either tissue culture plastic (Mid-
dle) or a 3T3 feeder (Right) and grown for 7 d in myoepithelial medium before
staining. Luminal contamination, as revealed by the presence of islets of K19+
cells, was strictly confined to tissue culture plastic. Nuclei are counterstained
with hematoxylin. (Scale bar: 200 μm.) (C) MEPs from three independent re-
duction mammoplasties enriched by the CD326/CD271 protocol were propa-
gated on 3T3 feeder cells under standard culture conditions (Epi medium) or a
medium devised for maintenance of myoepithelial properties (Myo medium).
Cells were counted and split consecutively at subconfluence. Accumulated
population doublings were recorded as a function of time. Notably, there was
no appreciable difference in longevity between the two culture protocols.
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Gauging Luminal Progenitor Formation from Anatomically Well-
Defined MEPs Reveals Region-Specific Multipotency in TDLUs. We
next addressed whether the heterogeneous K19 staining in
TDLUs and the homogeneous staining in ducts are the result of
region-specific myoepithelial progenitor cell activity. We com-
pared the potential of MEPs from the two locations with respect
to generation of K19+ luminal progenies in culture and in vivo.
To induce luminal differentiation, we used an established pro-
tocol based on small-molecule TGF-β receptor inhibition (22,
29) combined with fibroblast feeder deprivation. First, we com-
pared the frequency of MEPs with K19-forming capability in
cultures from biopsies with a high content of TDLUs versus bi-
opsies with a high content of ducts (up to sixfold higher, esti-
mated as large ducts per total number of cells) (Fig. 5A). The
K19+ colony-forming ability was significantly lower in cultures
derived from biopsies with a relatively high content of TDLUs
compared with those with a high content of ducts (Fig. 5 B and D
and SI Appendix, Fig. S7). Both sources of MEPs were able to
generate structures upon transplantation into the mammary fat
pad of NOG mice (Fig. 5C), and all transplantations resulted in
structure formation (four of each). However, similar to the
generation of K19+ luminal progenies in culture, a lower number
of K19+ profiles out of the total number of profiles was consis-
tently observed when MEPs were derived from TDLU-enriched
biopsies compared with the number of profiles derived from
duct-enriched biopsies (Fig. 5 C and D). The positive correlation
observed between K19+ colony-forming units in culture and
K19+ profiles in mice (Spearman’s rank correlation coefficient:
ρ = 0.93, P < 0.005; SI Appendix, Fig. S8) implied that the culture
assay was useful as a surrogate readout of progenitor cell activity.
The progenitors’ ability to generate K19+ colonies was estimated
to a frequency of 4.3 ± 3.7%, which is close to the frequencies of
formation of mammospheres from aldeflour dehydrogenase-
positive cells [∼4% (30)] and daughter colony-forming cells from
mammary repopulating units [4.1 ± 0.6% (6)] reported by others.
Also, luminal differentiation was not restricted to K19 only, as
other key luminal markers were induced in culture as assessed by
real-time (RT)-qPCR (SI Appendix, Fig. S9), and the luminal layer
in MEP-derived structures in vivo further included expression of
MUC1 and estrogen receptor-α (SI Appendix, Fig. S10).
If TDLUs and ducts indeed harbor different progenitor cell
compartments as suggested by the above experiments, this should
translate into a difference between MEPs derived from TDLUs
and ducts within the same breast biopsy sample. To address this,
we established MEP cultures from uncultured TDLU and duct
organoids microcollected directly under a phase-contrast micro-
scope (4), trypsinized into single cells, and sorted by FACS using
the CD326/CD271 protocol (Fig. 6 A and B). These MEP cultures
were further cloned for quantification of clonal capacity (Fig. 6D,
Left), and the cloned cultures, in turn, were passaged to assess the
K19 differentiating potential (Fig. 6 C and D, Right). While the
clonal capacity of MEPs appeared similar in the two sites (Fig. 6D,
Left), the K19 differentiation potential was significantly higher in
duct-derived MEPs compared with those derived from TDLUs
(Fig. 6D, Right; two-way ANOVA, P < 0.05). This suggests that
the difference in K19 luminal differentiation is determined by a
difference in progenitor cell potential between the two sites rather
than by the number of progenitors per se.
With the aim of identifying markers useful for prospective
isolation in bulk of duct versus TDLU MEPs, we screened a
series of biopsies for surface and surrogate markers specific for
duct MEPs. In all biopsies tested, we found that duct MEPs, as
opposed to those from TDLUs, consistently stained for a small
membrane glycoprotein, podoplanin (PDPN; reviewed in ref. 31)
(Fig. 7A). These cells stained strongly with a candidate surrogate
cytoskeletal marker, K17 (Fig. 7A). Based on this observation,
we used a CD326/CD271/PDPN FACS-based protocol to pro-
spectively isolate duct-derived MEPs (Fig. 7B). Smears of cells
sorted by FACS and stained for K17 confirmed the specificity of
this protocol for duct-derived PDPNhigh MEPs (Fig. 7B; 52 ± 8%
K17+ cells in the PDPNhigh preparation versus 6 ± 3% in the
PDPNlow preparation). Whereas plating of single cells in myoe-
pithelial medium on feeders revealed no significant difference in
colony-forming ability between the two sources of MEPs, further
passaging of clones under differentiating conditions revealed
that only duct-derived PDPNhigh clones were able to form ho-
mogeneous K19+ colonies (Fig. 7C, Right). Whenever K19 was
present in TDLU-derived clones, it was heterogeneously expressed,
mostly with a scattered pattern of relatively small-sized colonies
(Fig. 7C, Left). Collectively, these data are in strong favor of the
existence of two functionally different stem cells in TDLUs and
ducts of the normal human breast.
We finally addressed whether the heterogeneous and homo-
geneous expression of K19 observed in TDLU-derived and duct-
derived MEP clones, respectively, might be a consequence of
their progenitor cell potential (i.e., multipotency vs. bipotency).
To that end, we transplanted enriched or cloned MEPs to the fat
pad of NOG mice and stained by multicolor imaging for K19,
Fig. 3. Myoepithelial-derived cells in serial-passage subculture refrain
from luminal conversion and exhibit an epithelial or myoepithelial phe-
notype depending on medium composition. Representative micrographs
of myoepithelial-derived cells on 3T3 feeders grown in Epi medium (Left;
n = 14 biopsies) or Myo medium (Right; n = 20 biopsies) stained with immu-
noperoxidase against K19, K14, α-smooth muscle actin (α-sma), and vimentin.
Nuclei were counterstained with hematoxylin. Note that whereas all cells ex-
press K14, mesenchymal vimentin and α-sma are restricted to cells maintained
under the myoepithelial culture protocol. (Scale bar: 500 μm.)














α-smooth muscle actin, and K7, with the latter being a general
marker of luminal breast epithelial cells. As a control, staining of
TDLUs and ducts in sections of normal breast biopsies was in-
cluded (Fig. 8). Luminal cells generated from MEPs derived
from ducts stained uniformly with both K19 and K7 (Fig. 8B;
100 ± 0% K19+/K7+), while luminal cells from TDLUs that were
otherwise K19− stained positive with K7 only (Fig. 8A; 100%
K7+, of which 7 ± 0.6% were K19+/K7+). Thus, the two sources
of progenitor cells essentially recapitulated the TDLU and duct
lineage generation observed in situ (Fig. 8 C and D). This indi-
cates that the entire structure, including the MEPs derived from
TDLUs, results from differentiation of multipotent progenitors
as opposed to those from ducts, which derive from bipotent
progenitors. Taken together, these results demonstrate a novel
trajectory of cells in the anatomical region most susceptible to
development of breast cancer.
Discussion
Several lines of evidence indicate that TDLUs are the pre-
dominant source of future breast cancers and that a high TDLU
count is associated with genetic susceptibility variants and pre-
dicts higher breast cancer risk (32–35). The present work reveals
that two functionally different progenitor cells reside within the
myoepithelial lineage of the breast in the adult human: one as-
sociated with TDLUs and another localized to interlobular ducts.
Furthermore, the TDLU-derived progenitors are responsible for a
characteristic acquired heterogeneity within the luminal lineage,
which is most frequently observed later in adulthood. However, a
linear relationship between K19 heterogeneity and age cannot be
established, perhaps reflecting that other factors, such as re-
productive history, may influence the individual profile. In the
present biopsy material, we do not have access to information about
parity, for example, but the biopsies donated by women <21 y of age
most likely represent nulliparous women. Indeed, parity is known to
influence the molecular signature of human breast epithelial cells
(36, 37). Whether parity-induced changes in cellular composition
contribute to this altered profile remains to be elucidated. The
results nevertheless indicate that TDLU-derived myoepithelial
progenitor cells potentially contribute to the luminal lineage in the
adult, and thus should be considered as candidate cells of origin of
human breast cancer. The underlying mechanism for progenitor
cell contribution remains to be established, and, at present, it
Fig. 4. Myodifferentiation of myoepithelial-derived cells depends on culture conditions. (A) Heat map of selected differentially expressed genes in
NMMEPs or myodifferentiated MEPs. Whereas NMMEP transcripts are high in skin- and keratinocyte-associated transcripts (orange bar), MEP transcripts
are high in actin- and myosin-associated transcripts (blue bar). Log2-scaled expression values are presented for each gene, and the color key indicates the
z-score (n = 2 biopsies). (B) Representative multicolor imaging of cryostat sections from xenografted NOG mice 8 wk after injection in the mammary fat
pad of NMMEP-derived cells (Left; eight inoculations from three biopsies) or myoepithelial-derived cells (Right; 13 inoculations from six biopsies) stained
against α-smooth muscle actin (α-sma; green) or K10 (red). Nuclei are counterstained with DAPI (blue). Note that whereas the myoepithelial-derived cells
form relevant double-layered acini with a basal layer of α-sma+ MEPs, the NMMEP-derived cells form skin-like keratin pearls are negative for α-sma and
positive for K10. (Scale bars: 50 μm.)
E10106 | www.pnas.org/cgi/doi/10.1073/pnas.1714063114 Fridriksdottir et al.
cannot be excluded that region-specific heterogeneity is due to
an age-dependent impairment of differentiation capacity in
bipotent progenitors. This would be consistent with previous
findings that differentiation-defective multipotent progenitors
accumulate with age (38–40). Also, future studies may reveal
further complexity within the adult stem cell compartment in
terms of subsets with a different repopulating activity and re-
sponse to physiological stimuli, as demonstrated in the mouse
gland (41). The findings presented here emphasize the myoe-
pithelial lineage as an attractive target for the investigation of
such mechanisms and of agents that promote or interfere with
the formation of luminal breast cancer precursor cells.
Fig. 5. TDLUs differ from ducts by their ability to generate K19+ cells. (A) Low-
magnification micrographs of cryostat sections of two independent biopsies
with a high content of TDLUs (P941) and ducts (P939), respectively. Sections
were stained with hematoxylin to highlight the histological differences
(blue). (B) Low-magnification micrographs of generated luminal progenitor
clones from MEP cultures derived from TDLU-enriched or duct-enriched
biopsies stained with immunoperoxidase against K19 (brown) and nuclei
(blue). The clones were digitized by image processing for area measure-
ments. Note the higher number and larger clones in duct-derived cultures
(Right) compared with the TDLU-derived cultures (Left). (C) Multicolor im-
aging of structures derived from MEP cultures from TDLU-enriched and
duct-enriched biopsies transplanted to NOG mice in a humanized microen-
vironment with human breast fibroblasts and collagen I and Matrigel, and
stained against K19 (red), α-smooth muscle actin (α-sma; green), and nuclei
(blue). Whereas TDLU-derived morphogenesis was mainly heterogeneous
with respect to K19 staining, the duct-derived profiles were generally ho-
mogeneously positive. (D) Histograms of quantification of luminal pro-
genitor clones [K19+ colony-forming units (CFUs) per square unit] in culture
(Left) and luminal K19+ structures in vivo (percentage of K19+ profiles in
vivo) in corresponding xenografts (Right) of MEPs from TDLU biopsies (gray
bar, 11 inoculations from four biopsies) or duct biopsies (black bar, 11 inoc-
ulations from four biopsies). A significantly higher frequency of K19+ clones
and structures is generated from MEPs from duct biopsies [error bars in-
dicate SDs; Student’s t test: *P = 0.0034 (culture clones), *P = 2.48 E−5 (in vivo
structures)]. (Scale bars: A and B, 500 μm; C, 50 μm.)
Fig. 6. TDLUs differ from ducts by K19 expression potential in MEP-derived
clones. (A) Phase-contrast micrographs of microcollected TDLUs (Left) and
ducts (Right). Only TDLUs without visible subtending ducts were selected for
collection. (Scale bars: 100 μm.) (B) Representative FACS diagrams of trypsi-
nized, microcollected TDLUs and ducts labeled with CD326 and CD271. The
circles indicate the gating strategy, and the CD326/CD271 profiles of TDLUs
and ducts are quite similar. (C) Second-passage clones in 24 well dishes
stained with immunoperoxidase against K19 (brown) obtained from 96-well
dishes with CD271high single cells from TDLUs (Left) and ducts (Right), re-
spectively. (Right) While all wells contain growing clones, in this particular
biopsy, only CD271high-derived clones from ducts are able to differentiate
into keratin K19+ descendants (circled wells). (D) Representative frequencies
of colony-forming units from 96-well plates containing single CD271high cells
from three independent biopsies (Left; P952, P653, and P964) and their
corresponding ability to convert into K19+ descendants upon luminal dif-
ferentiation (Right). TDLUs and ducts apparently exhibit an approximately
similar capacity to form colonies (Left); however, within each biopsy, a sig-
nificantly higher number of K19+ clones are generated from ducts (Right)
(two-way ANOVA test, *P < 0.05).














We have previously demonstrated the existence of luminal-
derived human breast stem cells or progenitors based on the
differentiation repertoire of cultured luminal epithelial cells and
MEPs (11). This concurs nicely with the finding that human
normal luminal progenitors are developmentally plastic and
generate multilayered acinar structures when transplanted into
female immunocompromised mice (14, 42). Subsequently, we
further narrowed down the phenotype of candidate stem/pro-
genitor cells in the human breast to a suprabasal K14+/K19+ cell
with a preferential ductal localization (4, 13). Here, we identify
progenitor activity by the appearance of K19+ clones on a K14+
background. We therefore suspect that the previously described
K14+/K19+ suprabasal progenitors are very closely related to at
least the ductal myoepithelial-derived progenitors in the present
study. Indeed, the K14/K19 readout currently seems to be the
most operational surrogate marker for progenitor cells in culture
within the context of the human breast (39, 43).
The TDLU is an anatomical structure which is permanently
present, particularly in the human breast. Even in the nulliparous
state, the human breast is more developmentally advanced than
that of the adult mouse mammary gland (reviewed in ref. 44).
However, the human TDLU does not remain static throughout a
lifetime. Both in terms of size and molecular markers, it changes
with endocrinological and reproductive history (45). Most of the
cellular turnover responsible for such hormone-induced TDLU
remodeling takes place within the luminal epithelial lineage (4).
Whether or not bona fide stem cells play a role has remained an
open question. This is of interest because, in most tissues, stem
cells are believed to stay long enough within the tissue to sustain
and accumulate the mutations necessary for cellular trans-
formation (46). Indeed, in the human breast, stem cells have
been compellingly demonstrated using a transplantation protocol
based on severely immunocompromised mice (6, 7). As in the
mouse mammary gland, the human breast stem cells are em-
bedded within the myoepithelial lineage (8). This implies that a
potential contribution of human breast stem cells to human
breast cancer should be traceable to the myoepithelial lineage.
Surprisingly, in mice, although cellular turnover at homeostasis
seems to be strictly maintained by self-duplication within the
lineages, disturbance (e.g., upon single-cell transplantation or
activation of oncogenic pathways) leads to destabilization of the
Fig. 7. Only duct-derived MEPs generate homogeneously K19+ clones.
(A) Representative immunoperoxidase stainings of cryostat sections of normal
breast TDLUs with PDPN (Left) and K17 (Right). Nuclei are counterstained
with hematoxylin (blue). A coordinate staining with the surface marker
PDPN and the intracellular K17 is observed in ducts only. (B) FACS diagram of
trypsinized breast tissue exposed to a CD326/CD271/PDPN protocol. (Left)
Circles indicate the approximate gating strategy. (Right) Sorted PDPNhigh/
CD271high (PDPNhigh) and PDPNlow/CD271high (PDPNlow) single cells were
smeared and stained by fluorescence against K17 (red) and nuclei by DAPI
(blue). Clearly, the PDPNhigh/CD271high gate prospectively selects for duct-
derived MEPs. (C) Low-magnification micrograph of representative single-cell
clones from TDLU-derived (PDPNlow) and duct-derived (PDPNhigh) differenti-
atedMEP clones stained by immunoperoxidase against K19 (brown) and nuclei
(blue). Homogeneous staining for K19 was confined to duct-derived MEP
clones. (Scale bars: A and B, 50 μm; C, 500 μm.)
Fig. 8. TDLU- and duct-derived progenitors are multipotent and bipotent,
respectively. Multicolor imaging of cryostat sections from microcollected
enriched TDLU-derived (A) and single-cell–cloned duct-derived (B) MEPs in-
oculated into the fat pad of NOG mice (MEPs in vivo) compared with TDLUs
(C) and ducts of human breast tissue (in situ) (D) stained with K19 (red), K7
(green), and α-smooth muscle actin (α-sma; blue). Whereas single-cell–cloned
duct-derived progenitors consistently exhibited only two cell types [i.e., K7+/
K19+ luminal cells (yellow), α-sma+ MEPs (blue); structures formed from one
of three clones, three inoculations in two mice], the TDLU-derived progen-
itors, as an indication of multipotency, additionally gave rise to heterogeneous
profiles consisting of two luminal cell populations, of which one expressed
K7 only, as well as a population of α-sma+ MEPs (blue; microcollected TDLUs,
four inoculations in four mice). (Scale bar: 50 μm.)
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myoepithelial phenotype and conversion into luminal precursor
cells, and eventually luminal cancer (3, 47, 48). Due to the pres-
ence of permanently active TDLUs in the human gland, distur-
bances of tissue homoeostasis are likely to be more frequent on a
lifetime scale than in mice. Consequently, TDLU-resident myoe-
pithelial stem cells are likely to contribute progenitors to the lu-
minal lineage more often in humans. Intriguingly, microdissection
with the purpose of isolating morphologically distinct regions of
apparently normal breast tissue adjacent to breast cancer has
revealed a “field effect” in which some of the genetic aberrations
found in the invasive cancer were also present in neighboring
normal TDLUs (49, 50). Importantly, Deng et al. (49) found that
TDLUs more distant to the tumor were quite normal. It was
concluded that loss of heterozygosity (LOH) in certain TDLUs
confers focal increased risk of breast cancer, which may impact
on the risk of tumor recurrence. The finding of LOH in human
TDLUs is in strong favor of a clonal origin of this structure.
Nevertheless, our data are in favor of the idea that even though
the myoepithelial lineage, presumably in fetal life, arises clon-
ally in common antecedents (51), in the adult, luminal pro-
genitors within TDLUs are fueled in a facultative manner by
progenitor cells which have undergone some alteration in dif-
ferentiation repertoire with adulthood (reviewed in ref. 52).
Whether other factors, such as reproductive history or use of
oral contraceptives, additionally influence this differentiation
pattern is currently unknown.
We and others have previously argued that although tumor-
derived MEPs do not exhibit gross genomic alterations, they are
phenotypically severely abnormal (53, 54). Here, we find luminal
progenies in TDLUs of adults of older age. This finding may
concur with previous observations on TDLUs from BRCA car-
riers in which LOH is not necessarily the result of very early
aberrations but is acquired later (55). Thus, genetic alterations
vary from one clone to another in the tissue and extend beyond a
single TDLU, suggesting an acquired instability within the entire
area of the breast (55).
The exact mechanism by which aberrant TDLUs predispose to
breast cancer remains unknown. However, the sheer number of
TDLUs and the number of acini per TDLU have been associated
with the presence of known cancer genetic susceptibility variants
(33). Also, signaling pathways controlling the cellular composi-
tion of the human breast have been explored for cancer risk
assessment and prevention (56, 57). For example, differentiated
MEPs have been shown to be tumor-suppressive (58), the activity
of stem cell-related signaling in P27+ progenitors correlates with
the risk of developing breast cancer (56), and BMP2 levels in-
fluence the conversion of preneoplastic stem cells into luminal
breast cancer (57).
The paradigm identified here for the topographical genera-
tion of luminal progenitors from myoepithelial progenitors
within human breast TDLUs may impact on the general con-
cept of cell of origin in human breast cancer. Thus, the cell of
origin determines the phenotype of a derived tumor by both its
initial chromatin state and its transcriptional priming, which
eventually translate into tumor aggressiveness (59). We spec-
ulate that in targeting stem cells or progenitors in the human
breast with respect to modeling tumor evolution, it is in-
dispensable to take into account specifically the TDLU. If this
is proven correct, it may facilitate understanding of the func-
tional diversity of human breast tumors and further the devel-
opment of precision medicine.
Materials and Methods
Tissue. Normal breast biopsies were collected from healthy women un-
dergoing reduction mammoplasty for cosmetic reasons. Donors were in-
formed before surgery and agreed by written consent to donate tissue.
The use of human material has been reviewed by the Regional Scientific
Ethical Committees (Region Hovedstaden) and approved with reference to
H-2-2011-052. The only available information about the donors is their age
at the time of surgery. Material from some of the biopsies had been in-
cluded in previous studies. Normal breast tissue was prepared, and epi-
thelial organoids and fibroblasts were isolated as previously described
(60). The epithelial organoids were either used directly or frozen in liquid
nitrogen for later use (90% FBS/10% dimethyl sulfoxide; Sigma–Aldrich).
FACS. For analysis of epithelial cell composition and sorting of single cells,
epithelial organoids or microcollected TDLUs and ducts were trypsinized for
5–10 min in 0.25% trypsin and 1 mM EDTA solution under rotation at 37 °C.
Trypsination was stopped by addition of FBS and followed by filtration
through 100-μm mesh (Streno). Single cells were suspended in Hepes buffer
supplemented with 0.5% BSA (fraction V; Sigma–Aldrich) and 2 mM EDTA
(Merck), pH 7.5. To separate MEPs from luminal cells and optimize purifi-
cation of MEPs, the suspended cells were incubated for 45 min at 4 °C in the
presence of fluorochrome-conjugated monoclonal antibodies according
to three different protocols: EpCAM/CD326-AF488 (9C4, 1:50; BioLegend)
or CD326-BV421 (EBA-1, 1:50; BD Biosciences) in combination with p75
neurotrophin receptor p75(NTR)/CD271-allophycocyanin (APC) (ME20.4, 1:50;
Cedarlane Laboratories), EpCAM/CD326-AF647 (9C4, 1:50; BioLegend) in
combination with CD29-AF488 (TS2/16, 1:50; BioLegend), or EpCAM/CD326-
AF647 in combination with CD49f-FITC (GoH3, 1:50; BD Biosciences) (SI Ap-
pendix, Table S1). The former protocol isolating CD326low/CD271high cells
was employed in subsequent experiments.
Cell Culture. For establishment and serial passage of ultrapure myodiffer-
entiated MEPs, sorted primary MEPs (n = 30 biopsies) were plated on a
confluent layer of irradiated NIH 3T3 feeder cells (20 Gy, 4–8 × 103 cells per
square centimeter) in basic breastoid medium without Hepes (BBMYAB,
modified from ref. 26), here called Myo medium, and NMMEPs were prop-
agated in FAD2 medium (modified from refs. 27, 61), here called Epi me-
dium. Details are provided in SI Appendix.
Cell Propagation, Differentiation, and Clonal Colony Formation. Growth curves
were established from three different biopsies as parallel cultures in Epi or
Myo medium and plotted as population doublings versus time. For each
passage, 2,000–20,000 cells per square centimeter were plated on fibroblast
feeders and counted manually with a counter chamber at 80–90% conflu-
ence. Population doublings were calculated as n = 3.32(log UCY − log I) + X,
where n is population doubling, UCY is cell yield, I is inoculum number, and
X is population doubling of inoculum.
Luminal differentiation was induced as detailed in SI Appendix.
Microcollected ducts and TDLUs (n = 4 biopsies) were manually separated
under an inverted phase-contrast microscope as previously described (4).
Collected organoids were prepared for sorting as described in SI Appendix.
For generation of single-cell clones (either from microcollected TDLUs and
ducts or from PDPNhigh and PDPNlow cells), cells were sorted with the auto-
mated cell deposition unit (ACDU) unit of FACSAria/FACSFusion into a 96-
well plate (five cells per well) preplated with irradiated NIH 3T3 feeders in
the presence of myoepithelial medium and monitored for the establishment
of epithelial islets for 2–3 wk. Wells with the appearance of two islets or
more were discarded. When islets reached a sufficient size for further
propagation, cells were trypsinized and plated in 24-well plates under cul-
ture conditions that induce luminal differentiation. In some cases, a portion
of the MEPs were plated onto new feeders for further expansion before in
vivo transplantation.
In Vivo Transplantation. Animal experiments were performed with permission
from the Animal Experiments Inspectorate (J.nr. 2012-15-2934-00571) and
performed as described in SI Appendix.
RNA Isolation, RT-qPCR, and RNA-Sequencing Analysis. For RT-qPCR, CD326low/
CD271high cells were cultured in Myomedium on feeders for 9 d and passaged to
collagen-coated cultures with MEGM and RepSox without feeders to generate
luminal progenitors. After 13 d, the cells were sorted by FACS upon incubation
with CD117 to isolate generated CD117high K19+ progenitors for comparison
with MEPs, and upon RNA extraction, RT-qPCR was performed with primers
listed in SI Appendix, Table S2. A list of significantly differentially expressed
genes was established based on the noise sequencing (NOIseq) method.
Immunohistochemistry and Cytochemistry. Cryostat sections, smears of cells
sorted by FACS, and monolayer cultures were prepared and stained by
immunoperoxidase or immunofluorescence essentially as previously de-
scribed (4, 10, 62), and antibodies are listed in SI Appendix, Table S1.














Western Blotting. Whole-cell lysates of MEPs were prepared in passages 2, 5,
and 7, and blotting was performed as described in SI Appendix.
Statistics. All statistical analyses were performed by the statistical computing
program R (version 3.3.2). The Mann–Whitney U test was applied for com-
parison of two nonparametric groups, an interquartile range method was
used for identifying outliers, a two-way ANOVA analysis or Student’s t test
was used for testing difference between two groups, and a Spearman’s rank
correlation test was used for determination of significant correlation be-
tween two variables.
All other materials and methods can be found in SI Appendix, SI Materials
and Methods.
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